Login

The article explores how technology is disrupting home insurance, featuring insights from Lemonade Inc. CEO. 00:10:00

Share On Facebook Share On Twitter

John has served as LivePerson's CEO since January 2024.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Michael Roberts, HSBC CEO for the US and Americas, discusses efforts to rebuild the bank's operations and strategy.
00:10:00
Carmat's clinical developments, production capabilities, and financial situation | Stéphane Piat, CEO, Carmat SA.
00:10:00
Johan Hårdén, CEO at Allgon is interviewed about the start of 2020 and what lies ahead | Ola Samelius, EXECUTIVE PRESIDENT, Allgon AB (publ) ALLG B:STO
00:10:00
First Class Metals: Diverse Mineral Exploration in Northwestern Ontario
00:10:00
Rumble Resources Expands High-Grade Gold Potential at Western Queen Project
00:10:00
Silver Project PEA Exceeds Expectations with 85.7% IRR and $1.14B NPV
00:10:00
SanLam's Strong Financial Performance and Confidence in Future Growth | Paul Hanratty, CEO , Sanlam Limited.
00:10:00
Understanding Investment Risks with CEO Mike LaMena of Wealthspire Advisors | Mike LaMena, CEO, Wealthspire Advisors.
00:10:00
Evli Fund Management Company Ltd. provides insights into the market outlook for infrastructure investments.
00:10:00
Joey Zwillinger on Allbirds' Sustainable Revolution and Leading in the Green Economy | Joey Zwillinger, CEO, Allbirds Inc.
00:10:00
Iain Evans, Chief Business Development Officer at Polar Capital LLP - Expert in Global Business Strategy and Asset Management
00:10:00
Bidvest Reports Strong Financial Performance in 2023 | Mpumi Madisa - CEO of Bidvest Group

© 2017 - Neuhu+